Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Revenue

Beam Therapeutics had revenue of $7.47M in the quarter ending March 31, 2025, with 0.81% growth. This brings the company's revenue in the last twelve months to $63.58M, down -82.38% year-over-year. In the year 2024, Beam Therapeutics had annual revenue of $63.52M, down -83.18%.

• Revenue (ttm): $63.58M
• Revenue Growth: -82.38%
• P/S Ratio: 22.42
• Revenue / Employee: $131,631
• Employees: 483
• Market Cap: 1.64B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	63.52M	-314.19M	-83.18%
Dec 31, 2023	377.71M	316.79M	520.01%
Dec 31, 2022	60.92M	9.08M	17.51%
Dec 31, 2021	51.84M	51.82M	215,916.67%
Dec 31, 2020	24.00K	6.00K	33.33%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.